Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Debopam Samanta

Concepts (331)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Epilepsy
28
2024
180
12.750
 Why?
Anticonvulsants
17
2025
123
7.330
 Why?
Seizures
22
2024
195
5.560
 Why?
Spasms, Infantile
11
2025
29
4.360
 Why?
Tuberous Sclerosis
7
2024
36
4.240
 Why?
Cannabidiol
7
2024
40
3.910
 Why?
Status Epilepticus
6
2021
36
3.420
 Why?
Epilepsies, Myoclonic
5
2024
12
3.190
 Why?
Mutation
16
2023
1280
3.150
 Why?
Deep Brain Stimulation
4
2025
43
2.910
 Why?
Humans
113
2025
50503
2.630
 Why?
Electroencephalography
18
2024
304
2.570
 Why?
Intellectual Disability
5
2023
127
2.230
 Why?
Brain
10
2024
1319
2.180
 Why?
Child
40
2025
6906
2.150
 Why?
Hemiplegia
3
2021
11
2.070
 Why?
Developmental Disabilities
5
2019
120
1.720
 Why?
Epilepsy, Absence
3
2019
11
1.680
 Why?
Magnetic Resonance Imaging
16
2025
1548
1.640
 Why?
Algorithms
2
2025
625
1.450
 Why?
Infant
22
2025
3628
1.450
 Why?
Tumor Suppressor Proteins
3
2023
128
1.430
 Why?
Neuroaxonal Dystrophies
2
2022
8
1.430
 Why?
Nervous System Malformations
3
2020
17
1.420
 Why?
Folate Receptor 1
2
2022
25
1.400
 Why?
Infant, Newborn, Diseases
2
2020
56
1.310
 Why?
Epilepsies, Partial
2
2022
12
1.310
 Why?
Ketamine
2
2020
59
1.300
 Why?
Child, Preschool
20
2025
3942
1.190
 Why?
Neurocutaneous Syndromes
2
2019
6
1.180
 Why?
Cadherins
2
2019
63
1.150
 Why?
Cerebral Arteries
2
2019
37
1.080
 Why?
Epilepsy, Generalized
2
2023
8
1.060
 Why?
Vigabatrin
3
2024
3
1.050
 Why?
Sirolimus
2
2017
62
1.040
 Why?
Angiofibroma
2
2015
5
1.010
 Why?
Facial Neoplasms
2
2015
22
0.990
 Why?
Nerve Tissue Proteins
2
2018
194
0.980
 Why?
Valproic Acid
2
2022
31
0.970
 Why?
Vagus Nerve Stimulation
1
2025
12
0.950
 Why?
Stroke
3
2019
495
0.930
 Why?
Fenfluramine
2
2024
8
0.930
 Why?
Randomized Controlled Trials as Topic
2
2024
573
0.920
 Why?
Male
35
2025
25907
0.920
 Why?
Dioxolanes
2
2024
14
0.910
 Why?
Thalamus
1
2024
38
0.910
 Why?
Female
31
2025
27081
0.900
 Why?
Pregnanolone
2
2023
6
0.890
 Why?
Landau-Kleffner Syndrome
1
2022
3
0.830
 Why?
Treatment Outcome
11
2025
5283
0.830
 Why?
Quality Improvement
2
2022
209
0.800
 Why?
Aphasia
1
2022
33
0.790
 Why?
Nervous System Diseases
2
2021
89
0.780
 Why?
Chromosome Deletion
3
2019
134
0.770
 Why?
Abnormalities, Multiple
3
2023
167
0.760
 Why?
Emergencies
1
2021
79
0.730
 Why?
Pharmaceutical Preparations
1
2021
76
0.730
 Why?
Angelman Syndrome
1
2020
1
0.710
 Why?
Transition to Adult Care
1
2020
17
0.710
 Why?
Bone Diseases, Developmental
2
2023
14
0.700
 Why?
Tooth Abnormalities
2
2023
12
0.690
 Why?
Immunoglobulins, Intravenous
1
2021
65
0.690
 Why?
Oligonucleotides, Antisense
1
2020
27
0.680
 Why?
Phenobarbital
1
2020
17
0.680
 Why?
Behavioral Symptoms
1
2019
3
0.680
 Why?
Flunarizine
1
2019
1
0.670
 Why?
Immunologic Factors
1
2021
111
0.670
 Why?
Excitatory Amino Acid Antagonists
1
2020
51
0.670
 Why?
Ocular Physiological Phenomena
1
2019
4
0.660
 Why?
Tetrasomy
1
2019
2
0.660
 Why?
Chromosomes, Human, Pair 5
1
2019
15
0.660
 Why?
Agenesis of Corpus Callosum
2
2018
11
0.660
 Why?
Sneddon Syndrome
1
2019
3
0.650
 Why?
Livedo Reticularis
1
2019
5
0.650
 Why?
Oral Ulcer
1
2019
3
0.650
 Why?
Calcium Channel Blockers
1
2019
62
0.650
 Why?
Behcet Syndrome
1
2019
7
0.650
 Why?
Transposases
1
2019
10
0.640
 Why?
Andersen Syndrome
1
2019
1
0.640
 Why?
Spinal Cord Diseases
1
2019
37
0.640
 Why?
Hydrocephalus
1
2019
43
0.640
 Why?
Receptors, GABA-B
1
2019
11
0.630
 Why?
Vitiligo
1
2019
8
0.630
 Why?
Genetic Therapy
1
2020
120
0.630
 Why?
Leukoencephalopathies
1
2019
14
0.630
 Why?
Autoimmune Diseases of the Nervous System
1
2019
9
0.630
 Why?
Nephrotic Syndrome
2
2017
18
0.630
 Why?
Cytochrome-c Oxidase Deficiency
1
2018
3
0.630
 Why?
Migraine Disorders
2
2020
44
0.630
 Why?
Edema
1
2019
69
0.620
 Why?
Cerebral Infarction
1
2018
37
0.620
 Why?
Alopecia
1
2019
29
0.620
 Why?
Electron Transport Complex IV
1
2018
24
0.620
 Why?
Muscle Weakness
1
2019
45
0.620
 Why?
Cannabinoid Receptor Agonists
1
2019
51
0.610
 Why?
Physicians
1
2022
232
0.610
 Why?
Optic Atrophy
1
2018
16
0.610
 Why?
Diffuse Cerebral Sclerosis of Schilder
1
2018
8
0.610
 Why?
Amino Acyl-tRNA Synthetases
1
2018
6
0.610
 Why?
Photic Stimulation
1
2018
55
0.610
 Why?
Shab Potassium Channels
1
2018
2
0.610
 Why?
Brain Edema
1
2018
41
0.600
 Why?
Parents
1
2021
318
0.600
 Why?
Lymphohistiocytosis, Hemophagocytic
1
2018
27
0.600
 Why?
Thrombocytopenia
1
2019
81
0.590
 Why?
Autoimmune Diseases
1
2019
79
0.590
 Why?
Myoclonus
1
2018
9
0.590
 Why?
Artifacts
1
2018
54
0.590
 Why?
Mitochondrial Diseases
1
2018
41
0.590
 Why?
Biomedical Research
1
2021
244
0.590
 Why?
Neurodegenerative Diseases
1
2018
77
0.570
 Why?
Practice Guidelines as Topic
1
2020
468
0.570
 Why?
Hearing Loss, Sensorineural
1
2018
76
0.560
 Why?
Osteochondrodysplasias
1
2017
12
0.560
 Why?
Health Knowledge, Attitudes, Practice
1
2021
491
0.560
 Why?
Immunologic Deficiency Syndromes
1
2017
19
0.550
 Why?
Adolescent
13
2024
6443
0.550
 Why?
Models, Biological
1
2020
716
0.550
 Why?
Arteriosclerosis
1
2017
53
0.550
 Why?
Phenotype
2
2021
739
0.550
 Why?
Infant, Newborn
6
2024
2749
0.550
 Why?
Carotid Artery Diseases
1
2017
33
0.550
 Why?
Drug Discovery
1
2017
85
0.540
 Why?
Child Development
1
2018
192
0.530
 Why?
Prenatal Exposure Delayed Effects
1
2018
182
0.530
 Why?
Skin
1
2019
388
0.530
 Why?
Cafe-au-Lait Spots
1
2016
2
0.530
 Why?
Erythema Infectiosum
1
2015
3
0.510
 Why?
Migraine with Aura
1
2015
4
0.510
 Why?
Williams Syndrome
1
2016
26
0.510
 Why?
Corpus Callosum
2
2023
28
0.510
 Why?
Leukoencephalitis, Acute Hemorrhagic
1
2015
3
0.510
 Why?
Sinus Pericranii
1
2015
1
0.510
 Why?
Syndrome
6
2024
240
0.510
 Why?
Parvovirus B19, Human
1
2015
17
0.510
 Why?
Toes
1
2015
15
0.510
 Why?
Pulmonary Embolism
1
2017
99
0.510
 Why?
SOS1 Protein
1
2015
2
0.500
 Why?
Electrodiagnosis
1
2015
12
0.500
 Why?
Crying
1
2015
4
0.500
 Why?
Moyamoya Disease
1
2015
7
0.500
 Why?
Hyperventilation
1
2015
8
0.500
 Why?
Iatrogenic Disease
1
2015
24
0.500
 Why?
Tuberculoma
1
2015
2
0.500
 Why?
Epilepsy, Benign Neonatal
1
2015
2
0.500
 Why?
Noonan Syndrome
1
2015
12
0.500
 Why?
Neurologic Examination
1
2015
76
0.500
 Why?
Encephalitis
1
2016
40
0.500
 Why?
Communication
3
2022
250
0.490
 Why?
Mutism
1
2015
3
0.490
 Why?
Ocular Motility Disorders
1
2015
17
0.490
 Why?
NAV1.2 Voltage-Gated Sodium Channel
1
2015
3
0.490
 Why?
TOR Serine-Threonine Kinases
1
2015
78
0.480
 Why?
Repressor Proteins
2
2023
148
0.480
 Why?
Diagnosis, Differential
7
2020
1033
0.480
 Why?
Trisomy
1
2014
27
0.480
 Why?
Influenza, Human
1
2015
86
0.470
 Why?
KCNQ2 Potassium Channel
1
2014
9
0.460
 Why?
Energy Drinks
1
2014
6
0.460
 Why?
Neurology
1
2015
42
0.460
 Why?
Vasoconstriction
1
2014
56
0.460
 Why?
Benzodiazepines
1
2014
70
0.450
 Why?
Osteomyelitis
1
2015
128
0.450
 Why?
Membrane Proteins
1
2016
332
0.440
 Why?
Sleep
1
2014
181
0.430
 Why?
Enzyme Inhibitors
1
2015
377
0.420
 Why?
Magnetic Resonance Angiography
3
2019
71
0.400
 Why?
Immunosuppressive Agents
3
2019
225
0.400
 Why?
Consensus
2
2025
160
0.390
 Why?
Pediatrics
1
2015
283
0.380
 Why?
Quality of Life
3
2022
851
0.370
 Why?
Receptors, N-Methyl-D-Aspartate
2
2022
127
0.350
 Why?
Diffusion Magnetic Resonance Imaging
3
2017
125
0.350
 Why?
Clinical Trials as Topic
2
2024
486
0.340
 Why?
Caregivers
2
2021
217
0.330
 Why?
Recurrence
3
2019
659
0.320
 Why?
Echinocandins
1
2008
64
0.300
 Why?
Mycoses
1
2008
155
0.280
 Why?
Gastroesophageal Reflux
2
2019
50
0.280
 Why?
Retrospective Studies
7
2025
6263
0.270
 Why?
Antifungal Agents
1
2008
331
0.260
 Why?
Administration, Topical
2
2015
57
0.250
 Why?
Seizures, Febrile
1
2024
2
0.240
 Why?
Meta-Analysis as Topic
1
2024
38
0.240
 Why?
Intralaminar Thalamic Nuclei
1
2024
6
0.230
 Why?
Adult
5
2024
13577
0.230
 Why?
Databases, Factual
2
2024
673
0.220
 Why?
Psychosurgery
1
2023
4
0.220
 Why?
Laser Therapy
1
2023
83
0.210
 Why?
Speech Disorders
1
2022
16
0.210
 Why?
Ethosuximide
1
2022
5
0.200
 Why?
Clonazepam
1
2022
6
0.200
 Why?
Electrodes, Implanted
1
2022
30
0.200
 Why?
Cluster Analysis
1
2023
219
0.200
 Why?
Stereotaxic Techniques
1
2022
38
0.200
 Why?
Death, Sudden
1
2022
10
0.200
 Why?
GTPase-Activating Proteins
1
2022
23
0.200
 Why?
Palliative Care
1
2024
190
0.190
 Why?
Concept Formation
1
2021
12
0.190
 Why?
Perivascular Epithelioid Cell Neoplasms
1
2021
4
0.190
 Why?
Freedom
1
2021
3
0.190
 Why?
Diazepam
1
2021
17
0.190
 Why?
Folic Acid
1
2022
139
0.190
 Why?
Drug Interactions
1
2022
206
0.190
 Why?
Fibroma
1
2021
37
0.190
 Why?
Adrenocorticotropic Hormone
2
2022
31
0.180
 Why?
Risk Factors
2
2020
3724
0.180
 Why?
Personal Satisfaction
1
2021
78
0.180
 Why?
Soft Tissue Neoplasms
1
2021
54
0.180
 Why?
Brain Diseases
1
2021
83
0.180
 Why?
Dihydroergotamine
1
2020
4
0.180
 Why?
Perception
1
2021
116
0.170
 Why?
Transcription Factors
2
2023
565
0.170
 Why?
Facies
2
2023
33
0.170
 Why?
Diet Therapy
1
2020
8
0.170
 Why?
Genetic Diseases, Inborn
1
2020
20
0.170
 Why?
Clinical Protocols
1
2020
110
0.170
 Why?
Treatment Failure
1
2020
118
0.170
 Why?
Anesthetics
1
2020
36
0.170
 Why?
Ubiquitin-Protein Ligases
1
2020
95
0.170
 Why?
Leukomalacia, Periventricular
1
2019
12
0.170
 Why?
Muscle Hypotonia
1
2019
21
0.160
 Why?
Chromosomes, Human, Pair 7
1
2019
29
0.160
 Why?
Learning
1
2021
159
0.160
 Why?
Patient-Centered Care
1
2021
130
0.160
 Why?
HLA-B51 Antigen
1
2019
2
0.160
 Why?
Matrix Attachment Region Binding Proteins
1
2020
37
0.160
 Why?
Qualitative Research
1
2021
349
0.160
 Why?
Craniofacial Abnormalities
1
2019
27
0.160
 Why?
Ventriculoperitoneal Shunt
1
2019
26
0.160
 Why?
Analgesics, Non-Narcotic
1
2020
117
0.160
 Why?
Heart Septal Defects, Atrial
1
2019
46
0.160
 Why?
Potassium Channels, Inwardly Rectifying
1
2019
7
0.160
 Why?
Ventricular Premature Complexes
1
2019
7
0.160
 Why?
Disease Management
1
2020
178
0.160
 Why?
Microcephaly
1
2019
41
0.160
 Why?
Melkersson-Rosenthal Syndrome
1
2018
4
0.160
 Why?
Facial Nerve Diseases
1
2018
6
0.160
 Why?
Referral and Consultation
1
2021
288
0.160
 Why?
Syncope
1
2019
29
0.160
 Why?
Nocturnal Myoclonus Syndrome
1
2018
13
0.150
 Why?
Cerebral Veins
1
2018
15
0.150
 Why?
Facial Paralysis
1
2018
23
0.150
 Why?
Anti-Arrhythmia Agents
1
2019
80
0.150
 Why?
Deglutition Disorders
1
2019
77
0.150
 Why?
Health Personnel
1
2021
247
0.150
 Why?
Acute Disease
1
2019
373
0.150
 Why?
Fatal Outcome
1
2019
197
0.150
 Why?
Video Recording
1
2018
79
0.150
 Why?
Frameshift Mutation
1
2018
16
0.150
 Why?
Fibrinolytic Agents
1
2019
125
0.150
 Why?
Combined Modality Therapy
1
2020
641
0.150
 Why?
Anti-Inflammatory Agents
1
2019
163
0.150
 Why?
Fear
1
2018
84
0.150
 Why?
India
1
2017
53
0.140
 Why?
Platelet Aggregation Inhibitors
1
2019
174
0.140
 Why?
Cerebellum
1
2018
131
0.140
 Why?
History, 21st Century
1
2017
56
0.140
 Why?
History, 20th Century
1
2017
100
0.140
 Why?
Neurotoxicity Syndromes
1
2017
46
0.140
 Why?
Methotrexate
1
2017
72
0.140
 Why?
Pandemics
1
2021
563
0.140
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2017
81
0.140
 Why?
Anti-Infective Agents
1
2017
95
0.130
 Why?
Animals
3
2022
13124
0.130
 Why?
Aldehyde Dehydrogenase
1
2016
25
0.130
 Why?
Hormones
1
2016
57
0.130
 Why?
Influenza B virus
1
2015
4
0.130
 Why?
Delayed Diagnosis
1
2016
24
0.130
 Why?
Chromosomes, Human, Pair 3
1
2015
18
0.130
 Why?
Arkansas
1
2021
1985
0.130
 Why?
North America
1
2015
65
0.130
 Why?
Cerebral Angiography
1
2015
97
0.120
 Why?
Antibiotics, Antineoplastic
1
2015
77
0.120
 Why?
Chromosomes, Human, Pair 9
1
2014
13
0.120
 Why?
Brain Waves
1
2014
16
0.120
 Why?
Complementary Therapies
1
2015
25
0.120
 Why?
Drug Resistance
1
2015
65
0.120
 Why?
Antiemetics
1
2014
31
0.110
 Why?
Polymerase Chain Reaction
1
2015
449
0.110
 Why?
Headache
1
2014
75
0.110
 Why?
Glutamine
1
2015
175
0.110
 Why?
Mutation, Missense
1
2014
103
0.110
 Why?
Vomiting
1
2014
70
0.110
 Why?
Arginine
1
2015
187
0.110
 Why?
Decision Making, Computer-Assisted
1
2013
4
0.110
 Why?
Analgesics
1
2014
116
0.110
 Why?
Diagnostic Errors
1
2013
66
0.100
 Why?
Evidence-Based Medicine
1
2013
253
0.100
 Why?
Inflammation
1
2016
610
0.090
 Why?
Pregnancy
1
2018
2452
0.090
 Why?
Signal Transduction
1
2017
1624
0.090
 Why?
Antineoplastic Agents
1
2017
1172
0.080
 Why?
Dysentery
1
2009
1
0.080
 Why?
Trichuriasis
1
2009
1
0.080
 Why?
Trichuris
1
2009
1
0.080
 Why?
Anesthesia, Intravenous
1
2008
12
0.080
 Why?
Eosinophils
1
2009
40
0.080
 Why?
Lipopeptides
1
2008
63
0.080
 Why?
Amyloidosis
1
2009
81
0.080
 Why?
Inflammatory Bowel Diseases
1
2009
52
0.070
 Why?
Tuberculosis
1
2009
130
0.070
 Why?
Candidiasis
1
2008
111
0.070
 Why?
Aspergillosis
1
2008
124
0.070
 Why?
Kidney Diseases
1
2009
213
0.070
 Why?
Prospective Studies
2
2023
2378
0.070
 Why?
Spasm
1
2024
9
0.060
 Why?
Observer Variation
1
2024
139
0.060
 Why?
Feedback
1
2024
53
0.050
 Why?
Kaplan-Meier Estimate
1
2025
464
0.050
 Why?
Probability
1
2023
164
0.050
 Why?
Neuroimaging
1
2023
87
0.050
 Why?
Neurosurgical Procedures
1
2024
124
0.050
 Why?
Potassium Channels
1
2021
33
0.050
 Why?
Registries
1
2024
563
0.050
 Why?
Reproducibility of Results
1
2024
1197
0.040
 Why?
Administration, Intravenous
1
2020
70
0.040
 Why?
Sleep Stages
1
2020
41
0.040
 Why?
Age of Onset
1
2020
108
0.040
 Why?
Cognition
1
2022
346
0.040
 Why?
Follow-Up Studies
1
2025
2242
0.040
 Why?
Immunohistochemistry
1
2021
957
0.040
 Why?
Software
1
2013
276
0.020
 Why?
Internet
1
2013
259
0.020
 Why?
Young Adult
1
2020
4102
0.020
 Why?
Antinematodal Agents
1
2009
2
0.020
 Why?
Mebendazole
1
2009
2
0.020
 Why?
Leukemoid Reaction
1
2009
6
0.020
 Why?
Antitubercular Agents
1
2009
102
0.020
 Why?
Colonoscopy
1
2009
100
0.020
 Why?
Prognosis
1
2009
1978
0.010
 Why?
Samanta's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (331) concept(s)
_
Co-Authors Expand Description
See all (13) people
_
Similar People Expand Description
See all (31) people
_
Same Department Expand Description
Search Department